Zagreb, Croatia

Jonuz Rizvani

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jonuz Rizvani: Innovator in Antiviral Pharmaceutical Composition

Introduction

Jonuz Rizvani is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in developing antiviral agents. His innovative work focuses on a novel coumarin derivative that has potential therapeutic applications.

Latest Patents

Rizvani holds a patent for a coumarin derivative as an antiviral agent, which includes its pharmaceutical composition, preparation, and use. The invention discloses a novel coumarin derivative of formula (1), detailing its synthesis and the composition required for therapeutic administration. This pharmaceutical composition is designed to be a safe and effective therapeutic agent for viral diseases, including acquired immunodeficiency syndrome (AIDS). He has 1 patent to his name.

Career Highlights

Jonuz Rizvani is associated with I-nova Medicinska Istrazivanja D.o.o., where he applies his expertise in pharmaceutical research. His work has contributed to advancements in antiviral therapies, showcasing his commitment to improving public health through innovative solutions.

Collaborations

Rizvani collaborates with professionals in his field, including colleagues Mladen Trkovnik and Milan Cacic. These partnerships enhance the research and development process, fostering an environment of innovation and shared knowledge.

Conclusion

Jonuz Rizvani is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to antiviral agents. His work exemplifies the importance of research and collaboration in developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…